End-of-day quote
Taipei Exchange
03:30:00 30/04/2024 am IST
|
5-day change
|
1st Jan Change
|
249.5
TWD
|
+1.01%
|
|
+2.46%
|
+3.53%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Capitalization
1 |
19,680
|
24,762
|
21,053
|
20,325
|
24,550
|
24,703
|
-
|
Enterprise Value (EV)
1 |
19,680
|
24,762
|
21,053
|
20,325
|
24,550
|
24,703
|
24,703
|
P/E ratio
|
29.4
x
|
33.5
x
|
19.8
x
|
13.3
x
|
16.9
x
|
16.6
x
|
15
x
|
Yield
|
2.91%
|
2.35%
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
6.59
x
|
7.05
x
|
4.87
x
|
4.05
x
|
5.08
x
|
4.91
x
|
4.45
x
|
EV / Revenue
|
6.59
x
|
7.05
x
|
4.87
x
|
4.05
x
|
5.08
x
|
4.91
x
|
4.45
x
|
EV / EBITDA
|
17
x
|
17.9
x
|
-
|
-
|
11
x
|
12.7
x
|
12.3
x
|
EV / FCF
|
3,97,65,184
x
|
5,18,60,233
x
|
-
|
-
|
-
|
-
|
-
|
FCF Yield
|
0%
|
0%
|
-
|
-
|
-
|
-
|
-
|
Price to Book
|
5.45
x
|
6.44
x
|
4.84
x
|
4.07
x
|
4.58
x
|
4.35
x
|
-
|
Nbr of stocks (in thousands)
|
1,01,867
|
1,01,867
|
1,01,867
|
1,01,867
|
1,01,867
|
1,01,867
|
-
|
Reference price
2 |
193.2
|
243.1
|
206.7
|
199.5
|
241.0
|
242.5
|
242.5
|
Announcement Date
|
23/03/20
|
25/02/21
|
03/03/22
|
03/03/23
|
07/02/24
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Net sales
1 |
2,985
|
3,514
|
4,321
|
5,015
|
4,832
|
5,032
|
5,555
|
EBITDA
1 |
1,161
|
1,385
|
-
|
-
|
2,239
|
1,952
|
2,010
|
EBIT
1 |
831.5
|
1,015
|
1,436
|
1,830
|
1,773
|
1,891
|
2,169
|
Operating Margin
|
27.86%
|
28.89%
|
33.23%
|
36.49%
|
36.68%
|
37.58%
|
39.05%
|
Earnings before Tax (EBT)
1 |
825.7
|
979.8
|
1,423
|
2,049
|
1,890
|
1,931
|
2,169
|
Net income
1 |
671.3
|
741.9
|
1,068
|
1,538
|
1,458
|
1,486
|
1,651
|
Net margin
|
22.49%
|
21.11%
|
24.72%
|
30.66%
|
30.18%
|
29.53%
|
29.72%
|
EPS
2 |
6.576
|
7.265
|
10.44
|
14.99
|
14.25
|
14.59
|
16.20
|
Free Cash Flow
|
494.9
|
477.5
|
-
|
-
|
-
|
-
|
-
|
FCF margin
|
16.58%
|
13.59%
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (EBITDA)
|
42.64%
|
34.47%
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
73.73%
|
64.36%
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
5.624
|
5.714
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
23/03/20
|
25/02/21
|
03/03/22
|
03/03/23
|
07/02/24
|
-
|
-
|
Fiscal Period: December |
2019 S2
|
2021 Q3
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
---|
Net sales
1 |
1,526
|
1,164
|
1,235
|
1,279
|
1,316
|
1,186
|
1,290
|
1,191
|
1,196
|
1,156
|
1,173
|
1,258
|
1,288
|
1,313
|
1,378
|
EBITDA
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EBIT
1 |
-
|
399.1
|
448.5
|
477.1
|
519.4
|
385
|
518.3
|
449.9
|
443.3
|
361.1
|
415
|
455
|
495
|
527
|
532
|
Operating Margin
|
-
|
34.3%
|
36.31%
|
37.31%
|
39.49%
|
32.47%
|
40.17%
|
37.78%
|
37.08%
|
31.25%
|
35.38%
|
36.17%
|
38.43%
|
40.14%
|
38.61%
|
Earnings before Tax (EBT)
1 |
-
|
395.8
|
478.5
|
540.3
|
607.6
|
422.2
|
533.9
|
471.2
|
515.4
|
369.8
|
425
|
465
|
505
|
537
|
532
|
Net income
1 |
356.9
|
304.8
|
360.6
|
397.8
|
456.2
|
323.1
|
400.3
|
372.4
|
401.6
|
284.1
|
326
|
357
|
389
|
414
|
405
|
Net margin
|
23.38%
|
26.19%
|
29.19%
|
31.12%
|
34.68%
|
27.24%
|
31.02%
|
31.27%
|
33.59%
|
24.59%
|
27.79%
|
28.38%
|
30.2%
|
31.53%
|
29.39%
|
EPS
2 |
3.492
|
2.981
|
3.524
|
3.895
|
4.457
|
3.143
|
3.933
|
3.650
|
3.940
|
2.770
|
3.200
|
3.510
|
3.820
|
4.070
|
3.970
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
23/03/20
|
04/11/21
|
04/05/22
|
10/08/22
|
11/11/22
|
03/03/23
|
04/05/23
|
09/08/23
|
08/11/23
|
07/02/24
|
-
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Net Debt
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
|
495
|
477
|
-
|
-
|
-
|
-
|
-
|
ROE (net income / shareholders' equity)
|
18.7%
|
19.9%
|
-
|
-
|
28.2%
|
24.4%
|
23.7%
|
ROA (Net income/ Total Assets)
|
14.1%
|
14.8%
|
-
|
-
|
19.8%
|
18.5%
|
18.1%
|
Assets
1 |
4,750
|
5,030
|
-
|
-
|
7,370
|
8,028
|
9,117
|
Book Value Per Share
2 |
35.50
|
37.80
|
42.70
|
49.10
|
52.60
|
55.80
|
-
|
Cash Flow per Share
|
8.900
|
11.80
|
-
|
-
|
-
|
-
|
-
|
Capex
1 |
414
|
729
|
-
|
-
|
360
|
450
|
450
|
Capex / Sales
|
13.86%
|
20.73%
|
-
|
-
|
7.45%
|
8.94%
|
8.1%
|
Announcement Date
|
23/03/20
|
25/02/21
|
03/03/22
|
03/03/23
|
07/02/24
|
-
|
-
|
Last Close Price
242.5
TWD Average target price
281
TWD Spread / Average Target +15.88% Consensus |
1st Jan change
|
Capi.
|
---|
| +3.53% | 781M | | -.--% | 6.97B | | -11.41% | 2.91B | | -6.89% | 2.85B | | -27.64% | 1.83B | | -2.47% | 1.16B | | -6.63% | 1.07B | | -10.95% | 831M | | -11.10% | 737M | | -19.31% | 719M |
Testing Laboratories
|